Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery

Summary

This randomized clinical trial studies metformin hydrochloride in treating patients with pancreatic cancer that can be removed by surgery. Metformin hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Timeline

Start

2014-01

Primary completion

2015-03

Completion

2015-03

Outcome

Outcome not reported

Stopped (Enrollment): “Slow accrual”

Drugs

Indications